These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 8981130)
1. The cervico-vaginal epithelium during 20 cycles' use of a combined contraceptive vaginal ring. Roumen FJ; Boon ME; van Velzen D; Dieben TO; Coelingh Bennink HJ Hum Reprod; 1996 Nov; 11(11):2443-8. PubMed ID: 8981130 [TBL] [Abstract][Full Text] [Related]
2. The effects of a combined contraceptive vaginal ring releasing ethinyloestradiol and 3-ketodesogestrel on vaginal flora. Davies GC; Feng LX; Newton JR; Dieben TO; Coelingh-Bennink HJ Contraception; 1992 May; 45(5):511-8. PubMed ID: 1623721 [TBL] [Abstract][Full Text] [Related]
3. Preliminary report of unexpected local reactions to a progestogen-releasing contraceptive vaginal ring. Bounds W; Szarewski A; Lowe D; Guillebaud J Eur J Obstet Gynecol Reprod Biol; 1993 Feb; 48(2):123-5. PubMed ID: 8491331 [TBL] [Abstract][Full Text] [Related]
4. Effects of contraceptive vaginal ring treatment on vaginal bacteriology and cytology. Schwan A; Ahrén T; Victor A Contraception; 1983 Oct; 28(4):341-7. PubMed ID: 6667623 [TBL] [Abstract][Full Text] [Related]
5. Dysplasia and cytologic findings in 4,589 young women enrolled in diethylstilbestrol-adenosis (DESAD) project. Robboy SJ; Szyfelbein WM; Goellner JR; Kaufman RH; Taft PD; Richard RM; Gaffey TA; Prat J; Virata R; Hatab PA; McGorray SP; Noller KL; Townsend D; Labarthe D; Barnes AB Am J Obstet Gynecol; 1981 Jul; 140(5):579-86. PubMed ID: 7195652 [TBL] [Abstract][Full Text] [Related]
6. [The clinico-morphological and cytological characteristics of the ecto- and endocervix with the use of the oral contraceptive triregol]. Prilepskaia VN; Nazarova NM; Kondrikov NI Akush Ginekol (Mosk); 1993; (3):30-3. PubMed ID: 8048684 [TBL] [Abstract][Full Text] [Related]
7. Vaginal epithelial surface appearances in women using vaginal rings for contraception. Fraser IS; Lacarra M; Mishell DR; Alvarez F; Brache V; Lähteenmäki P; Elomaa K; Weisberg E; Nash HA Contraception; 2000 Feb; 61(2):131-8. PubMed ID: 10802278 [TBL] [Abstract][Full Text] [Related]
8. Histopathological and histochemical changes in the cervix uteri under contraceptive pills. El Hakim SM; Abdin FH; Kandil O Egypt Popul Fam Plann Rev; 1976 Dec; 10(2):20-33. PubMed ID: 12308408 [TBL] [Abstract][Full Text] [Related]
9. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response. Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746 [TBL] [Abstract][Full Text] [Related]
10. Cellular composition of cervical smears in relation to the day of the menstrual cycle and the method of contraception. Vooijs GP; van der Graaf Y; Elias AG Acta Cytol; 1987; 31(4):417-26. PubMed ID: 3604536 [TBL] [Abstract][Full Text] [Related]
11. A randomized comparison of the effects on vaginal and cervical epithelium of a placebo vaginal ring with non-use of a ring. Weisberg E; Fraser IS; Baker J; Archer D; Landgren BM; Killick S; Soutter P; Krause T; d'Arcangues C Contraception; 2000 Aug; 62(2):83-9. PubMed ID: 11102592 [TBL] [Abstract][Full Text] [Related]
12. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Mostad SB; Overbaugh J; DeVange DM; Welch MJ; Chohan B; Mandaliya K; Nyange P; Martin HL; Ndinya-Achola J; Bwayo JJ; Kreiss JK Lancet; 1997 Sep; 350(9082):922-7. PubMed ID: 9314871 [TBL] [Abstract][Full Text] [Related]
14. Effect of the combined steroidal contraceptives (Gynanovlar 21 and Lyndiol 2.5) on the human adrenocortical and ovarian activities. Zaki K; Kamal I; Talaat MM; Rashad S; Nour H Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):41-65. PubMed ID: 12256027 [TBL] [Abstract][Full Text] [Related]
15. Lea's Shield, a new barrier contraceptive preliminary clinical evaluations three-day tolerance study. Hunt WL; Gabbay L; Potts M Contraception; 1994 Dec; 50(6):551-61. PubMed ID: 7705097 [TBL] [Abstract][Full Text] [Related]
16. Cytological study in cases with intrauterine contraceptive device (Lippes' Loop). Aikat M; Pande M J Obstet Gynaecol India; 1968 Apr; 18(2):270-3. PubMed ID: 12331818 [TBL] [Abstract][Full Text] [Related]
17. The effects of frequent nonoxynol-9 use on the vaginal and cervical mucosa. Niruthisard S; Roddy RE; Chutivongse S Sex Transm Dis; 1991; 18(3):176-9. PubMed ID: 1658953 [TBL] [Abstract][Full Text] [Related]
18. Evaluating the efficacy and safety of a progestin- and estrogen-releasing ethylene vinyl acetate copolymer contraceptive vaginal ring. Nguyen BT; Jensen JT Expert Opin Drug Saf; 2014 Oct; 13(10):1423-30. PubMed ID: 25106828 [TBL] [Abstract][Full Text] [Related]
19. The vaginal contraceptive pill. Coutinho E IPPF Med Bull; 1985 Feb; 19(1):2-3. PubMed ID: 12339969 [TBL] [Abstract][Full Text] [Related]
20. Masking effect of hormonal contraceptives on discriminating quantitative features of visually normal intermediate cells in positive and negative cervical smears. Kwikkel HJ; Boon ME; van Rijswijk MM; Rietveld WJ; Stolk JG Anal Quant Cytol Histol; 1986 Sep; 8(3):227-32. PubMed ID: 3778614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]